Clinical Trial Update: Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib [Phase 1]

View source ↗

Summary

Phase 1 modular pharmacology study to evaluate drug-drug interaction potential and relative bioavailability of Saruparib; status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Saruparib (saruparib)

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Solid Malignancies | Phase 1 | Status: ACTIVE_NOT_RECRUITING